2023-09-012024-08-312024-08-31false10333422SPEIRS MEDICAL LIMITED2025-04-02falseiso4217:GBPxbrli:pure103334222023-09-01103334222024-08-31103334222023-09-012024-08-31103334222022-09-01103334222023-08-31103334222022-09-012023-08-3110333422bus:SmallEntities2023-09-012024-08-3110333422bus:AuditExempt-NoAccountantsReport2023-09-012024-08-3110333422bus:FullAccounts2023-09-012024-08-3110333422bus:PrivateLimitedCompanyLtd2023-09-012024-08-3110333422core:WithinOneYear2024-08-3110333422core:AfterOneYear2024-08-3110333422core:WithinOneYear2023-08-3110333422core:AfterOneYear2023-08-3110333422core:ShareCapital2024-08-3110333422core:SharePremium2024-08-3110333422core:RevaluationReserve2024-08-3110333422core:OtherReservesSubtotal2024-08-3110333422core:RetainedEarningsAccumulatedLosses2024-08-3110333422core:ShareCapital2023-08-3110333422core:SharePremium2023-08-3110333422core:RevaluationReserve2023-08-3110333422core:OtherReservesSubtotal2023-08-3110333422core:RetainedEarningsAccumulatedLosses2023-08-3110333422core:LandBuildings2024-08-3110333422core:PlantMachinery2024-08-3110333422core:Vehicles2024-08-3110333422core:FurnitureFittings2024-08-3110333422core:OfficeEquipment2024-08-3110333422core:NetGoodwill2024-08-3110333422core:IntangibleAssetsOtherThanGoodwill2024-08-3110333422core:ListedExchangeTraded2024-08-3110333422core:UnlistedNon-exchangeTraded2024-08-3110333422core:LandBuildings2023-08-3110333422core:PlantMachinery2023-08-3110333422core:Vehicles2023-08-3110333422core:FurnitureFittings2023-08-3110333422core:OfficeEquipment2023-08-3110333422core:NetGoodwill2023-08-3110333422core:IntangibleAssetsOtherThanGoodwill2023-08-3110333422core:ListedExchangeTraded2023-08-3110333422core:UnlistedNon-exchangeTraded2023-08-3110333422core:LandBuildings2023-09-012024-08-3110333422core:PlantMachinery2023-09-012024-08-3110333422core:Vehicles2023-09-012024-08-3110333422core:FurnitureFittings2023-09-012024-08-3110333422core:OfficeEquipment2023-09-012024-08-3110333422core:NetGoodwill2023-09-012024-08-3110333422core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3110333422core:ListedExchangeTraded2023-09-012024-08-3110333422core:UnlistedNon-exchangeTraded2023-09-012024-08-3110333422core:MoreThanFiveYears2023-09-012024-08-3110333422core:Non-currentFinancialInstruments2024-08-3110333422core:Non-currentFinancialInstruments2023-08-3110333422dpl:CostSales2023-09-012024-08-3110333422dpl:DistributionCosts2023-09-012024-08-3110333422core:LandBuildings2023-09-012024-08-3110333422core:PlantMachinery2023-09-012024-08-3110333422core:Vehicles2023-09-012024-08-3110333422core:FurnitureFittings2023-09-012024-08-3110333422core:OfficeEquipment2023-09-012024-08-3110333422dpl:AdministrativeExpenses2023-09-012024-08-3110333422core:NetGoodwill2023-09-012024-08-3110333422core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3110333422dpl:GroupUndertakings2023-09-012024-08-3110333422dpl:ParticipatingInterests2023-09-012024-08-3110333422dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3110333422core:ListedExchangeTraded2023-09-012024-08-3110333422dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3110333422core:UnlistedNon-exchangeTraded2023-09-012024-08-3110333422dpl:CostSales2022-09-012023-08-3110333422dpl:DistributionCosts2022-09-012023-08-3110333422core:LandBuildings2022-09-012023-08-3110333422core:PlantMachinery2022-09-012023-08-3110333422core:Vehicles2022-09-012023-08-3110333422core:FurnitureFittings2022-09-012023-08-3110333422core:OfficeEquipment2022-09-012023-08-3110333422dpl:AdministrativeExpenses2022-09-012023-08-3110333422core:NetGoodwill2022-09-012023-08-3110333422core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3110333422dpl:GroupUndertakings2022-09-012023-08-3110333422dpl:ParticipatingInterests2022-09-012023-08-3110333422dpl:GroupUndertakingscore:ListedExchangeTraded2022-09-012023-08-3110333422core:ListedExchangeTraded2022-09-012023-08-3110333422dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-09-012023-08-3110333422core:UnlistedNon-exchangeTraded2022-09-012023-08-3110333422core:NetGoodwill2024-08-3110333422core:IntangibleAssetsOtherThanGoodwill2024-08-3110333422core:LandBuildings2024-08-3110333422core:PlantMachinery2024-08-3110333422core:Vehicles2024-08-3110333422core:FurnitureFittings2024-08-3110333422core:OfficeEquipment2024-08-3110333422core:AfterOneYear2024-08-3110333422core:WithinOneYear2024-08-3110333422core:ListedExchangeTraded2024-08-3110333422core:UnlistedNon-exchangeTraded2024-08-3110333422core:ShareCapital2024-08-3110333422core:SharePremium2024-08-3110333422core:RevaluationReserve2024-08-3110333422core:OtherReservesSubtotal2024-08-3110333422core:RetainedEarningsAccumulatedLosses2024-08-3110333422core:NetGoodwill2023-08-3110333422core:IntangibleAssetsOtherThanGoodwill2023-08-3110333422core:LandBuildings2023-08-3110333422core:PlantMachinery2023-08-3110333422core:Vehicles2023-08-3110333422core:FurnitureFittings2023-08-3110333422core:OfficeEquipment2023-08-3110333422core:AfterOneYear2023-08-3110333422core:WithinOneYear2023-08-3110333422core:ListedExchangeTraded2023-08-3110333422core:UnlistedNon-exchangeTraded2023-08-3110333422core:ShareCapital2023-08-3110333422core:SharePremium2023-08-3110333422core:RevaluationReserve2023-08-3110333422core:OtherReservesSubtotal2023-08-3110333422core:RetainedEarningsAccumulatedLosses2023-08-3110333422core:NetGoodwill2022-09-0110333422core:IntangibleAssetsOtherThanGoodwill2022-09-0110333422core:LandBuildings2022-09-0110333422core:PlantMachinery2022-09-0110333422core:Vehicles2022-09-0110333422core:FurnitureFittings2022-09-0110333422core:OfficeEquipment2022-09-0110333422core:AfterOneYear2022-09-0110333422core:WithinOneYear2022-09-0110333422core:ListedExchangeTraded2022-09-0110333422core:UnlistedNon-exchangeTraded2022-09-0110333422core:ShareCapital2022-09-0110333422core:SharePremium2022-09-0110333422core:RevaluationReserve2022-09-0110333422core:OtherReservesSubtotal2022-09-0110333422core:RetainedEarningsAccumulatedLosses2022-09-0110333422core:AfterOneYear2023-09-012024-08-3110333422core:WithinOneYear2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:CostValuation2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3110333422core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3110333422core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3110333422core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3110333422core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3110333422core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3110333422core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3110333422core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3110333422core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3110333422core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3110333422core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3110333422core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3110333422core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3110333422core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3110333422core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3110333422core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3110333422core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3110333422core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3110333422core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3110333422bus:Director12023-09-012024-08-3110333422bus:Director22023-09-012024-08-31

SPEIRS MEDICAL LIMITED

Registered Number
10333422
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2024

SPEIRS MEDICAL LIMITED
Company Information
for the year from 1 September 2023 to 31 August 2024

Directors

SPEIRS, Archibald Joseph Daniel, Dr
SPEIRS, Rachael Andrea Dawn

Registered Address

28a The Hundred
Romsey
SO51 8BW

Registered Number

10333422 (England and Wales)
SPEIRS MEDICAL LIMITED
Balance Sheet as at
31 August 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets369,00827,502
69,00827,502
Current assets
Current asset investments4283,399212,599
Cash at bank and on hand199,466178,861
482,865391,460
Creditors amounts falling due within one year5(76,768)(76,844)
Net current assets (liabilities)406,097314,616
Total assets less current liabilities475,105342,118
Net assets475,105342,118
Capital and reserves
Called up share capital150150
Profit and loss account474,955341,968
Shareholders' funds475,105342,118
The financial statements were approved and authorised for issue by the Board of Directors on 2 April 2025, and are signed on its behalf by:
SPEIRS, Archibald Joseph Daniel, Dr
Director
Registered Company No. 10333422
SPEIRS MEDICAL LIMITED
Notes to the Financial Statements
for the year ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings25
Vehicles25
Office Equipment50
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Land & buildings

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 September 23-35,6164,16439,780
Additions28,88322,8965,04856,827
At 31 August 2428,88358,5129,21296,607
Depreciation and impairment
At 01 September 23-8,9043,37412,278
Charge for year-12,4022,91915,321
At 31 August 24-21,3066,29327,599
Net book value
At 31 August 2428,88337,2062,91969,008
At 31 August 23-26,71279027,502
4.Current asset investments
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables160-
Taxation and social security55,11246,510
Other creditors19,36628,204
Accrued liabilities and deferred income2,1302,130
Total76,76876,844